Skip to main content
Veterinary Medicines

TYLAN 200 000 UI/ML SOLUTION INJECTABLE

Authorised
  • Tylosin

Product identification

Medicine name:
TYLAN 200 000 UI/ML SOLUTION INJECTABLE
Active substance:
  • Tylosin
Target species:
  • Cattle
  • Pig
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Tylosin
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        108
        hour
    • Pig
      • Meat and offal
        16
        day
    • Sheep
      • Meat and offal
        42
        day
      • Milk
        108
        hour
    • Goat
      • Meat and offal
        42
        day
      • Milk
        108
        hour
  • Intravenous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0474355 6/1980
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."